Indications for the use of “Teknazole
” “Teknazole” is prescribed in vulvovaginal candidiasis, fungal diseases of the skin, eyes and oral cavity, fungal lesion of nails caused by dermatophytes or yeast, systemic mycosis (including aspergillese, candidiasis, cryptococcosis, sporotrichosis, histoplasmosis, blastomycosis, paracoccidioidosis and others).
In which dosages take “Teknazol”
The drug is released as capsules or solution for ingestion. Capsules take immediately after meal, solution – not less than an hour before meal. Dosing regimen – 1 once a day for 100 mg or 1-2 times a day for 200 mg. The duration of treatment is determined by the etiology of disease.
To treat candidiasis of the oral mucosa or esophagus, the solution is held in the mouth for 20 seconds, then swallowed.
Side effects of “Teknazola”
The application of “Teknazola” has a number of side effects. From the digestive system there can be abdominal pain, nausea and vomiting, constipation, increased activity of hepatic enzymes, cholestatic jaundice, in isolated cases hepatitis. From the nervous system possible headache, dizziness, in some cases – peripheral neuropathy. Swelling, including pulmonary edema, and congestive heart failure, may be observed from the heart and cardiovascular system. Allergic reactions to the drug manifest in the form of skin rash, urticaria, skin itching, angioedema, Stevens-Johnson syndrome.
With prolonged use of the drug, effects such as hair loss, dysmenorrhea and hypokalemia are possible.
Contraindications to the reception of “Teknazol”
“Teknazol” is contraindicated for children under 12 years and with hypersensitivity to components of the drug. You cannot take simultaneously with terfenadine, misolastine, astemizol, cisaprid, quinidine, dophetilide, pimoside, lovastatin, simvastatin, midazolam and triazolam.
In case of disorders of liver or kidney function, the drug is used under the control of its concentration in blood plasma. If necessary, dose correction is carried out.
Use of “Teknazol” in pregnancy and lactation
During pregnancy, the drug is used only for the treatment of systemic mycosis if the expected benefit to the mother exceeds the possible risk to the fetus. According to experimental studies, the acting substance “Teknazola” has a toxic effect on the embryo and can cause abnormalities of its development. If it is necessary to take the drug during lactation, the issue of suspension of breastfeeding is decided.